NextCell Pharma

CEO Mathias Svahn will present the Company, the report, and the results from the subgroup analysis published on 7 April 2025. The Company’s subsidiaries, Cellaviva and QVance, will also be presented by their respective CEOs: Sofie Falk Jansson (Cellaviva) and Lindsay Davies (QVance). Attendees, both on-site and online, will have the opportunity to ask questions. The presentation will be available for on-demand streaming.

Time: Friday, 25 April 2025, at 2:00 PM

Venue: Redeye, Mäster Samuelsgatan 42, Stockholm, Sweden

Registration (for on-site attendance): Please register by email to events@redeye.se

Webcast (no pre-registration required): Please follow this link:

https://www.redeye.se/events/1095576/business-update-nextcell-pharma